Vieworks Co., Ltd. (KOSDAQ:100120)
South Korea · Delayed Price · Currency is KRW 27,750
0.00 (0.00%)
Apr 24, 2026, 3:30 PM KST
Vieworks Revenue
In the year 2025, Vieworks had annual revenue of 239.33B KRW with 7.37% growth. Vieworks had revenue of 68.56B in the quarter ending December 31, 2025, with 14.75% growth.
Revenue
239.33B
Revenue Growth
+7.37%
P/S Ratio
1.00
Revenue / Employee
489.44M
Employees
489
Market Cap
238.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 239.33B | 16.44B | 7.37% |
| Dec 31, 2024 | 222.90B | 2.65B | 1.20% |
| Dec 31, 2023 | 220.25B | -17.68B | -7.43% |
| Dec 31, 2022 | 237.93B | 44.79B | 23.19% |
| Dec 31, 2021 | 193.14B | 32.88B | 20.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Value Added Technology | 426.42B |
| CLASSYS | 336.82B |
| T&L Co., Ltd. | 164.16B |
| BioNote | 118.32B |
| Dongbang Medical | 113.54B |
| Shinhung | 102.61B |
| PCL, Inc. | 4.98B |
| EOFLOW | 3.67B |